skip to main content
Show Results with:

Management of toxicities of immune checkpoint inhibitors

Spain, Lavinia; Diem, Stefan; Larkin, James

Cancer treatment reviews. Volume 44 (2016); pp 51-60 -- Elsevier

Online access

  • Title:
    Management of toxicities of immune checkpoint inhibitors
  • Author: Spain, Lavinia;
    Diem, Stefan;
    Larkin, James
  • Found In: Cancer treatment reviews. Volume 44 (2016); pp 51-60
  • Journal Title: Cancer treatment reviews
  • Subjects: Cancer--Périodiques; Cancer--Traitement--Périodiques; Neoplasms--therapy--Periodicals; Cancer--Periodicals; Cancer--Treatment--Periodicals; Cancer--Treatment; Periodicals; Immune-checkpoint inhibitors--Immune-related adverse events--Ipilimumab--Nivolumab--Pembrolizumab--Melanoma--Lung cancer--Renal cancer; Electronic journals; Dewey: 616.99406
  • Rights: legaldeposit
  • Publication Details: Elsevier
  • Abstract: Highlights:

    Role of immune checkpoint inhibition in the management of key malignancies.

    Description of rates of immune-related adverse events and timing of their onset.

    Management strategies for immune-related toxicities.


    Immune checkpoint inhibition with the anti-CTLA-4 antibody ipilimumab and the anti-PD-1 antibodies nivolumab and pembrolizumab has improved survival in metastatic melanoma, lung cancer and renal cancer. Use of these agents holds promise in other malignancies. The augmented immune response enabled by these agents has led to a particular group of side effects called immune-related adverse events (irAEs). The main irAEs include diarrhea, colitis, hepatitis, skin toxicities and endocrinopathies such as hypophysitis and thyroid dysfunction. The anti-PD-1 antibodies have a different toxicity profile to ipilimumab with fewer high grade events. This article identifies the rates of common and uncommon irAEs associated with each immune checkpoint inhibitor (ICPI) and their timing of onset, focusing mainly on the experience in melanoma and lung cancer. An approach to management for each class of irAE is provided.

  • Identifier: System Number: LDEAvdc_100031117036.0x000001; Journal ISSN: 0305-7372; 10.1016/j.ctrv.2016.02.001
  • Publication Date: 2016
  • Physical Description: Electronic
  • Shelfmark(s): ELD Digital store

Searching Remote Databases, Please Wait